Core Viewpoint - Anhui Xinruida Technology Co., Ltd. has approved a share repurchase plan to utilize 10 million to 20 million yuan of its own or special loan funds for equity incentives, adjusting the repurchase price ceiling due to the 2024 annual equity distribution [1] Group 1 - The company plans to repurchase shares using 10 million to 20 million yuan for equity incentives [1] - The repurchase price ceiling has been adjusted from 26.96 yuan/share to 26.71 yuan/share starting July 10 [1] - As of September 30, the company has repurchased a total of 187,900 shares, accounting for 0.0841% of the total share capital [1] Group 2 - The highest transaction price during the repurchase was 19.86 yuan/share, while the lowest was 19.747 yuan/share [1] - The total amount spent on the repurchase so far is 3,721,901.80 yuan, sourced from the company's own funds [1]

Core Viewpoint - Anhui Xinruida Technology Co., Ltd. has completed the registration change and obtained a new business license, reflecting an increase in registered capital from 222,329,498 RMB to 223,435,220 RMB [1][2]. Group 1: Company Information - The company is now registered with a capital of 223,435,220 RMB [2]. - The company is classified as a listed other joint-stock company [2]. - The legal representative of the company is Peng You [2]. - The company was established on May 15, 2012, and operates indefinitely [2]. - The business scope includes R&D, production, processing, and sales of electronic products, optoelectronic and display products, semiconductor integrated circuits, and related services [2]. Group 2: Registration Details - The company has completed the necessary registration change and updated its articles of association [1]. - The new business license was issued by the Hefei Market Supervision Administration [1]. - Other registration details remain unchanged [1].

Core Viewpoint - The company has completed the registration capital change and amended its articles of association, receiving a new business license from the local market supervision authority [1] Group 1 - The third meeting of the company's third board and the first extraordinary shareholders' meeting of 2025 approved the proposal for changing the registered capital and amending the articles of association [1] - The company has completed the necessary business registration changes and filing procedures [1] - The new business license was issued by the Hefei Market Supervision Administration [1]

证券代码：002983 证券简称：芯瑞达 公告编号：2025-058 安徽芯瑞达科技股份有限公司 关于完成工商变更登记并换发营业执照的公告 安徽芯瑞达科技股份有限公司（以下简称"公司"）第三届董事会第二十次 会议及2025年第一次临时股东会审议通过了《关于变更公司注册资本并修订<公司 章程>的议案》，具体内容详见公司于2025年8月28日和2025年9月17日刊登于《中 国证券报》以及巨潮资讯网（www.cninfo.com.cn）上的相关公告。 近日，公司完成了上述工商变更登记及《公司章程》备案手续，并取得了合肥 市市场监督管理局换发的《营业执照》，具体工商登记信息如下： 一、本次变更事项 变更前： 注册资本：人民币贰亿贰仟叁佰贰拾玖万肆仟伍佰玖拾捌圆整； 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 类型：其他股份有限公司（上市）； 变更后： 注册资本：人民币贰亿贰仟叁佰肆拾叁万伍仟贰佰贰拾圆整； 除上述信息外，其他登记事项不变。 二、变更后工商登记信息 名称：安徽芯瑞达科技股份有限公司； 统一社会信用代码：91340100595739962H； 住所： ...

Company Overview - Chiprayda Technology Co., Ltd. is located in Hefei Economic and Technological Development Zone, established on May 15, 2012, and listed on April 28, 2020 [2] - The company specializes in the research, design, production, sales, and technical services of new display optoelectronic systems and health intelligent light source systems [2] - Main business revenue composition: Display modules 88.12%, Display terminals 10.24%, Others 1.52%, Health intelligent light source 0.13% [2] Stock Performance - As of September 24, Chiprayda's stock price increased by 2.03% to 21.06 CNY per share, with a total market capitalization of 4.706 billion CNY [1] - Year-to-date stock price increase is 8.61%, with a decline of 2.50% over the last 5 trading days and a 7.18% decline over the last 20 days [2] - The stock has seen a 1.74% increase over the last 60 days [2] Financial Performance - For the period from January to June 2025, Chiprayda achieved operating revenue of 491 million CNY, representing a year-on-year growth of 1.90% [2] - The net profit attributable to shareholders was 66.5258 million CNY, showing a year-on-year increase of 24.28% [2] - Cumulative cash dividends since the A-share listing amount to 246 million CNY, with 167 million CNY distributed over the past three years [3] Shareholder Information - As of June 30, 2025, the number of shareholders is 22,900, a decrease of 2.96% from the previous period [2] - The average circulating shares per person increased by 3.05% to 5,596 shares [2] - New institutional shareholders include: - Bodao Yuanhang Mixed A (007126) as the fifth largest shareholder with 844,100 shares - Bodao Growth Zhihang Stock A (013641) as the sixth largest shareholder with 750,400 shares - Boshi Zhixuan Quantitative Multi-Factor Stock A (013465) as the seventh largest shareholder with 591,600 shares - Huazhong Happiness Life Mixed A (005136) as the ninth largest shareholder with 540,200 shares [3]

Group 1 - Shudao Equipment's subsidiary signed a construction contract worth 24.68 million yuan for a hydrogen fuel cell manufacturing base project [1] - Zhongliang Technology received a land acquisition compensation of 30 million yuan from the government [2] - Palm Holdings won a bid for a high-standard farmland construction project in Lankao County, with a contract value of 433 million yuan, accounting for 14.12% of the company's audited revenue for 2024 [3] Group 2 - Changchun Yidong's subsidiary received a government subsidy of 2.85 million yuan, which is 122.78% of the company's audited net profit for the last fiscal year [4] - Wuzhou Transportation successfully issued 200 million yuan in medium-term notes with an interest rate of 2.10% [5][6] - Tiandi Source's subsidiary plans to apply for a trust loan of up to 500 million yuan from related parties [8] Group 3 - Tiandi Source's subsidiary acquired a residential land use right in Xi'an for 2.015 billion yuan [9] - Opcon Vision received a medical device registration certificate for its ultrasonic nebulizer [11] - Jingjiawei announced the resignation of its vice president due to personal reasons [13] Group 4 - Fulinh Precision's subsidiary received a prepayment of 1.5 billion yuan from CATL for securing lithium iron phosphate material supply [15] - Yunzhu Technology's subsidiary received a government subsidy of 20.12 million yuan [16] - Kehua Bio's ferritin test kit received a medical device registration certificate [17] Group 5 - Jinghua Pharmaceutical's medical sodium alginate wound dressing received a medical device registration certificate [18] - Lingwei Technology established a wholly-owned subsidiary with a registered capital of 1 million yuan [19] - Sanwei Co. won a bid for concrete sleeper procurement projects worth 158 million yuan [20] Group 6 - Shanghai Pharmaceuticals' Nicardipine tablets passed the consistency evaluation for generic drugs [21] - Lushan New Materials increased its idle fund management limit to 750 million yuan [24] - Huayi Technology announced the retirement of a core technical staff member [25] Group 7 - Yingli Environment plans to use up to 300 million yuan of idle raised funds for cash management [30] - Yong'an Forestry plans to develop a national reserve forest project in Putian, Fujian, with an estimated investment of 154 million yuan [32] - Xinyuan Technology's shareholders plan to reduce their holdings by up to 3.18% of the company's shares [60]

Group 1 - On September 17, Junsheng Electronics disclosed an increase in shareholding, with Junsheng Group acquiring 700,000 A-shares during the period of unusual stock fluctuations [1][2] - A total of 29 A-share listed companies announced share reductions, including notable firms such as Shuanglu Pharmaceutical, Xinruida, and Boyun New Materials [1][2] Group 2 - Shuanglu Pharmaceutical's board secretary plans to reduce holdings by no more than 0.0365% of the company's shares [2] - Xinruida's shareholder Dai Yongjian intends to reduce holdings by no more than 0.13% [2] - Boyun New Materials' shareholder Gao Chuangtou plans to reduce holdings by no more than 1% [2] - Other companies with planned reductions include Guanggang Gas, Hanyi Co., and Weilan Lithium, with reductions ranging from 0.16% to 3.48% [2]

Group 1 - The core point of the article is that shareholder Dai Yongjian, who holds 273,409 shares (0.13% of the total share capital after excluding repurchased shares), plans to reduce his holdings by the same amount within a specified timeframe [2][2][2] Group 2 - The reduction of shares will occur through centralized bidding and is scheduled to take place from October 20, 2025, to January 19, 2026 [2]

Group 1 - The core point of the announcement is that the shareholder Dai Yongjian, who is one of the concerted actors of the controlling shareholder, plans to reduce his stake in the company by a maximum of 273,400 shares, which represents 0.13% of the total share capital after excluding shares held in the repurchase special account [1]

Group 1 - The core point of the article is that a major shareholder, Dai Yongjian, plans to reduce his stake in Chiprayda (002983.SZ) by selling up to 273,400 shares within three months after a 15 trading day period from the announcement date, which represents 0.13% of the company's total share capital excluding shares in the repurchase account [1]